New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

The molecular sensing technology can quickly analyze genes and pathogens, cutting diagnosis times to a matter of hours.

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking ...

Medically reviewed by Soma Mandal, MD A vitamin D test is a blood test that measures the level of vitamin D (calciferol) in ...

It provides a more precise prediction than currently available of how serious the case is by focusing on autoantibodies in ...